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ABSTRACT
Poly(ADP-ribose) (PAR) is synthesized by poly(ADP-
ribose) polymerases in response to genotoxic stress
and interacts non-covalently with DNA damage
checkpoint and repair proteins. Here, we present
a variety of techniques to analyze this interaction in
terms of selectivity and affinity. In vitro synthesized
PAR was end-labeled using a carbonyl-reactive
biotin analog. Binding of HPLC-fractionated PAR
chains to the tumor suppressor protein p53 and to
the nucleotide excision repair protein XPA was
assessed using a novel electrophoretic mobility
shift assay (EMSA). Long ADP-ribose chains
(55-mer) promoted the formation of three specific
complexes with p53. Short PAR chains (16-mer)
were also able to bind p53, yet forming only one
defined complex. In contrast, XPA did not interact
with short polymer, but produced a single complex
with long PAR chains (55-mer). In addition, we
performed surface plasmon resonance with immob-
ilized PAR chains, which allowed establishing
binding constants and confirmed the results
obtained by EMSA. Taken together, we developed
several new protocols permitting the quantitative
characterization of PAR–protein binding. Further-
more, we demonstrated that the affinity of the
non-covalent PAR interactions with specific binding
proteins (XPA, p53) can be very high (nanomolar
range) and depends both on the PAR chain length
and on the binding protein.
INTRODUCTION
The superfamily of poly(ADP-ribose) polymerases
(PARPs) comprises over a dozen proteins, which have
been identiﬁed in most eukaryotic organisms but are
absent in yeast and prokaryotes (1). PARP-1 is the best-
characterized member of this family and is activated via
binding to single- or double-strand breaks in DNA to
catalyze the transfer of ADP-ribose moieties from NAD
+
on acceptor proteins, thus producing protein-coupled
PAR chains (2), which can be degraded by poly(ADP-
ribose) glycohydrolase (PARG) in an endo- and exo-
glycosidic manner (3). Very recently two novel isoforms of
PARG have been identiﬁed, which possess mitochondrial
targeting sequences and may participate in the signaling
of PAR from the nucleus to mitochondria (4). PARP-1
represents the predominant target (‘acceptor’) protein
undergoing this covalent modiﬁcation, but other nuclear
proteins including p53, NF-kB, CSB and histones are
poly(ADP-ribosyl)ated as well (5–9). PARP-1 is function-
ally associated with DNA repair and contributes to the
maintenance of genomic stability thereby counteracting
cancer formation (10–15). PAR is a nucleic acid analog
and consists of a heterogeneous mixture of linear and
branched chains ranging from 2 up to 200 ADP-ribose
units in vivo (16). Owing to the ribose–phosphate–
phosphate–ribose backbone PAR has a higher negative
charge density as compared to DNA and was suggested
to exhibit a helical conformation (17). It was proposed
that non-covalent interactions with other molecules,
for example with constitutive components of chromatin,
play a crucial role in polymer function (18). It is conceiv-
able that non-covalent interactions with PAR depend
on chain length and branching complexity (19). Several
years ago Pleschke and colleagues (20) identiﬁed a
PAR-binding motif in a variety of proteins involved in
DNA damage checkpoint and repair. Non-covalent
interaction is mediated by a conserved consensus
sequence, which is frequently located within functional
protein domains. Binding was proposed to regulate
DNA–protein and protein–protein interactions as well
as protein degradation. Non-covalent binding of PAR
to p53 dramatically reduces its DNA-binding activity
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another protein harboring this consensus motif, speciﬁ-
cally interacts with poly(ADP-ribosyl)ated PARP-1 via
the PAR chains that are covalently attached to PARP-1.
Thus XRCC1 is recruited to the site of DNA damage
stimulating base excision repair (22,23). Topoisomerase 1,
which is also involved in genomic stability, possesses three
PAR-binding sites overlapping with structurally and
functionally important domains (24). PAR was shown
to reactivate stalled topoisomerase 1 and to promote DNA
strand break resealing. Very recently a physical and
functional interplay of protein kinase Ataxia telangiectasia
mutated (ATM), which is involved in the early DNA
damage response, and PAR has been established (25).
Moreover, PAR was demonstrated to associate with
mitotic spindles and to be required for spindle function
in Xenopus laevis egg extracts (26). The increasing number
of biological processes, in which PAR is involved,
highlights the importance of this complex biopolymer
(27). Binding of PAR to proteins is not only highly speciﬁc
but also very stable, e.g. histone H1–PAR complexes resist
phenol partitioning, high-salt washes and detergents (28).
So far, however, virtually nothing is known concerning the
selectivity and aﬃnity of this interaction. Merely histones
were characterized with regard to chain length using an
in vitro phenol-partitioning assay, which revealed a
preferential binding of histones to long and branched
ADP-ribose chains (28,29).
We established several novel methods to assess the non-
covalent interaction between PAR and speciﬁc binding
proteins as a function of PAR chain length. In particular,
we end-labeled ADP-ribose chains with a biotin moiety
and subsequently fractionated PAR by high-resolution
anion exchange HPLC to obtain ADP-ribose chains of
deﬁned length. In order to quantify the binding aﬃnities
to selected proteins (p53, XPA), we developed an electro-
phoretic mobility shift assay (EMSA) and used surface
plasmon resonance (SPR) to determine the binding
kinetics. We demonstrate for the ﬁrst time that non-
covalent PAR–protein interactions exhibit extraordinary
high aﬃnities (nanomolar range) and display a hitherto
unknown selectivity with regard to both chain length and
the binding protein.
MATERIALS AND METHODS
Material
Mouse monoclonal antibody 10H was immuno-puriﬁed on
a protein A column (Sigma) from culture supernatant of
10H hybridoma cells (30). Q Sepharose FastFlow was from
Amersham Biosciences and Ni-NTA Superﬂow was
purchased from Qiagen. TCA, EDTA and 40% acrylamide
solution (19:1) was from Roth. NaCl and ethanol were
obtained from Riedel-de Ha ¨ en.The octameric oligonucleo-
tide GGAATTCC was purchased from Invitrogen.
All other chemicals were obtained from Sigma-Aldrich.
Proteinexpression andpurification
Recombinant PARP-1 was overexpressed in Sf9 cells
using the baculovirus system and puriﬁed as described (31)
except that the oligo-dT/poly-A cellulose step was
replaced by a dsDNA-cellulose (Sigma) column chroma-
tography. p53 was overexpressed in High-Five insect cells
and isolated by anion exchange and DNA cellulose aﬃnity
chromatography (32,33). The cDNA encoding for XPA
was cloned into baculovirus expression vector pVL 1392
(BD Biosciences), expressed as His-tagged fusion protein
and puriﬁed by Ni-NTA chromatography followed by
DNA cellulose aﬃnity chromatography (34,35).
Synthesis andpurification of PAR
According to Kiehlbauch et al. (19), PAR was synthesized
with some modiﬁcations. Brieﬂy, PAR was synthesized
in a 20ml incubation mixture comprising 100mM Tris–
HCl pH 7.8, 10mM MgCl2, 1mM NAD
+, 10mM DTT,
60mg/ml histone H1, 60mg/ml histone type IIa, 50mg/ml
octameric ‘activator’ oligonucleotide GGAATTCC and
150nM human PARP-1. The reaction was stopped after
15min by addition of 20ml ice-cold 20% TCA. Following
precipitation the pellet was washed with ice-cold 99.8%
ethanol. Polymer was detached using 0.5M KOH/50mM
EDTA and puriﬁed as described (36). After extraction
with phenol–chloroform–isoamyl alcohol PAR was
precipitated with ethanol overnight. Following centrifuga-
tion PAR was air-dried and stored at 208C
Biotinylation of ADP-ribose chains
Typically 150nmol of puriﬁed PAR synthesized in vitro
were incubated under reductive amination conditions
in sodium acetate buﬀer pH 5.5 containing 4mM biocytin
hydrazide (Pierce) in a total volume of 500ml for 8h at
room temperature. Following dialysis overnight polymer
was precipitated with ethanol and concentrations were
determined using UV absorbance at 258nm (37). Success-
ful labeling was conﬁrmed by 20% native PAGE and
subsequent semi-dry blot onto a nylon membrane
(Amersham Biosciences). After blocking with 2% bovine
serum albumin (BSA) in Tris-buﬀered saline–Tween 20
(TBS-T) solution biotinylated PAR was detected by
streptavidin–POD (Amersham Biosciences). Bands
were visualized by chemiluminescence imaging using
a FujiLAS 1000.
HPLC fractionationof polymers and characterization
on sequencing gels
Polymer fractionation was performed using a Shimadzu
LC-8A HPLC system equipped with a semi-preparative
DNA Pac PA100 column (DIONEX). Five micromole of
puriﬁed, biotinylated PAR were applied to the column
and polymers were eluted using a multistep NaCl gradient
in 25mM Tris–HCl pH 9.0 modiﬁed from Kiehlbauch
et al. (19). Fractions were collected manually according
to UV absorbance at 258nm. Separated biotin-labeled
PAR was precipitated with ethanol, dissolved in 500ml
water and stored at 208C. Subsequently, ADP-ribose
polymers were characterized on modiﬁed sequencing gels
(18). Typically 50pmol of the respective fraction were
subjected to electrophoresis and separated polymers were
visualized using GELCODE Color silver stain (Pierce)
as described (36).
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Typically 15pmol of recombinant protein was vacuum
aspirated onto nitrocellulose membranes (Amersham
Biociences) using a slot-blot manifold (Schleicher &
Schuell). The membranes were cut into appropriate
pieces and these were incubated with 500pmol of
the respective ADP-ribose fraction in 5ml TBS-T. After
three washing steps with TBS-T containing 1M NaCl,
membranes were blocked with 5% (w/v) skim milk
powder in TBS-T, bound polymers were detected using
10H antibody and secondary peroxidase-conjugated anti-
mouse IgG (DakoCytomation). Bands were visualized
in the FujiLAS1000 device using enhanced chemilumines-
cence. Evaluation of blots was performed with AIDA
software (Raytest).
Affinity purification of biotinylated PAR
Prior to gel shift experiments end-biotinylated fractio-
nated PAR was aﬃnity-puriﬁed using SoftLink
TM Soft
Release Avidin Resin (Promega) as described in the user
manual. Brieﬂy, biotinylated polymer was diluted in bind
and wash (BW) buﬀer containing 50mM Tris–HCl
pH 8.0, 50mM NaCl to 2ml and applied to the resin.
The ﬂowthrough was collected and loaded once again.
Subsequently, the column was washed with 6ml BW
buﬀer and bound biotinylated PAR chains were gently
eluted in 1ml steps using 5mM D(+)-biotin. The puriﬁ-
cation process was monitored by native 20% PAGE
and detection was performed using streptavidin–POD and
enhanced chemiluminescence.
Eluted biotinylated PAR was pooled and dialyzed
against MilliQ water overnight. Thereafter samples were
lyophilized using a Speed Vac and dissolved in 100ml
MilliQ water. Concentration of aﬃnity-puriﬁed PAR was
determined by native PAGE using a 49-mer oligonucleo-
tide (Invitrogen) as standard.
PAR electrophoretic mobility shift assay
The protein of interest was incubated in an appropriate
volume of 10mM Tris–HCl pH 7.4, 1mM EDTA for
10min at 258C. Aﬃnity-puriﬁed biotinylated PAR of
deﬁned chain length (250fmol of 16-mer and 125fmol
of 55-mer, respectively) was added and complex formation
was allowed for 20min at 258C to reach equilibrium.
Subsequently the reaction mixture was supplemented
with 10 loading dye resulting in a ﬁnal volume of
25ml. The samples were electrophoresed through 5%
native polyacrylamide gels for 2.5h at 160V to separate
free and bound ADP-ribose polymer. Thereafter, samples
were transferred to a nylon membrane via semi-dry
blotting. Then the membrane was blocked with 2% BSA
in TBS-T and biotinylated ADP-ribose chains were
detected with streptavidin–POD. Blots were visualized
using a FujiLAS 1000 chemiluminescene imager and
quantiﬁcation was performed using AIDA Software.
Surface plasmon resonance
All SPR binding sensorgrams were obtained with
Biacore T100 and SA sensor chips (GE Healthcare).
Biotinylated PAR (14-mer or 63-mer) was immobilized
on a streptavidin-coated SA sensor chip. Brieﬂy, a 5nM
solution of the respective PAR chain in PBS buﬀer pH 7.4
was injected over the ﬂow cell to obtain a response level
of 8–12 RU (14-mer) and 3–5 RU (63-mer), respectively.
A reference cell without immobilized ligands was used
to subtract buﬀer refractive eﬀects and as a control for
unspeciﬁc binding. Furthermore, speciﬁcity of sensor
surface was checked using monoclonal antibody 10H as
positive control and BSA as negative control. The follow-
ing concentrations of 10H were injected: 0.01, 0.05, 0.1,
1.0, 2.0, 2 5.0 and 10nM at a ﬂow rate of 60ml/min, 120s
contact time, 600s dissociation time. This was followed
by a ﬁrst (30s contact time, 2M NaCl+0.1% SDS)
and a second regeneration step (60s contact time, 2M
NaCl+0.1% SDS). The following concentrations of
XPA were injected: 5.0, 10, 50, 2 100, 200, 300, 400
and 500nM. Flow rate was 50ml/min, 70s contact time,
600s dissociation time. This was followed by a ﬁrst
(60s contact time, 6M guanidine HCl) and a second
regeneration step (90s contact time, 2M NaCl+0.1%
SDS). For kinetic titration a 2-fold dilution series of p53
was injected as follows: 1000, 500, 250, 125 and 62.5nM
(for PAR 14-mer); 400, 200, 100, 50 and 25nM (for PAR
63-mer). Data evaluation was carried out using Biacore
T100 Evaluation 1.1.1. which allows the ﬁtting of experi-
mental data with implemented kinetic models. In the
case of kinetic titration, data were evaluated with
BIAevaluation software 4.1.
Statistical analysis
EMSA data are displayed as means+SEM. Each EMSA
experiment, done in triplicates, was performed at least
twice. The data obtained were analyzed using GraphPad
Prism 4 software, and KD values were calculated by using
a sigmoidal dose–response curve with variable slope.
Curves were ﬁtted using non-linear regression.
RESULTS
Terminal biotinylation ofPAR
A number of methods to study PAR function have been
established, but their power is often limited due to the
large heterogeneity of PAR. Several eﬀorts have been
made to fractionate this complex polymer according to
chain length (18,19,38). Despite successful small-scale
fractionation of PAR into deﬁned size classes no study has
been performed so far to investigate the impact of chain
length on PAR–protein interactions. Major obstacles
were the amount of ADP-ribose polymers required
and the lack of tools to detect interactions without using
PAR-speciﬁc antibodies.
We therefore set out to develop a new method for
speciﬁc end-labeling of PAR chains. Puriﬁed PAR
synthesized in vitro was coupled to biotin via a carbonyl-
reactive biotin analog (biocytin hydrazide) (Figure 1A).
This molecule attacks the reducing ribose terminus of the
polymer chain, forming a stable bond under reductive
amination conditions. The labeling reaction was time
dependent as monitored by semi-dry blotting and reached
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even very short ADP-ribose chains were eﬃciently
biotinylated, yet the pattern of biotinylated PAR did
reﬂect the distribution of synthesized ADP-ribose poly-
mers. In addition, we observed that the extent of labeling
depends on the incubation period used for detachment of
the polymer from the acceptor protein during PAR
puriﬁcation (Figure 1B, right panel). With increasing
time of incubation of the protein-coupled polymer under
strong alkaline conditions the yield of the terminal
biotinylation reaction decreased. This may be attributable
to the elimination of the terminal ribose moiety catalyzed
by strong bases (19). The overall yield of biotinylated
PAR was 10–20% as estimated by aﬃnity chromatogra-
phy/UV absorbance (data not shown).
In conclusion, we established speciﬁc biotin end-
labeling of PAR, which enables novel biochemical
analyses of this biopolymer, e.g. aﬃnity studies, employ-
ing streptavidin–biotin chemistry.
Binding ofPAR to immobilized proteins isinfluenced
bychain length
Terminally biotinylated PAR was fractionated according
to chain length using an anion exchange HPLC protocol
as described by Kiehlbauch et al. (19), with modiﬁcations.
The semi-preparative column we used permits the separa-
tion of 5–10mmol PAR in contrast to previous analytical
columns with a limit of only 100nmol PAR (19). The
fractions of biotinylated polymers were analyzed on modi-
ﬁed sequencing gels to assess chain length and purity.
Silver staining showed the successful separation of ADP-
ribose polymers of deﬁned size class ranging from 3 up to
70 ADP-ribose units (data not shown).
To assess the non-covalent binding of fractionated PAR
chains to proteins, a classical approach was chosen. Equal
amounts of each puriﬁed protein were immobilized on
a nitrocellulose membrane and bound ADP-ribose chains
were detected using the monoclonal PAR antibody 10H.
The human tumor suppressor protein p53 was previously
shown to interact in a non-covalent fashion with PAR and
harbors three potential PAR-binding sites (20). Since the
binding of PAR to p53 inﬂuences its DNA-binding acti-
vity we asked whether there was speciﬁcity for a certain
polymer size class. Surprisingly, ADP-ribose chains
ranging from 5 up to 39units bound rather poorly to
p53 (Figure 2A) whereas longer PAR chains displayed a
higher aﬃnity. Furthermore, the binding of separated
Figure 1. Terminal labeling of PAR chains. (A) Structure of the
carbonyl-reactive linker biocytin hydrazide. (B) Biotinylation of PAR
chains is time dependent. End-labeled PAR samples were subjected to
native PAGE and transferred to a nylon membrane. Detection was
performed using streptavidin–POD. The panel on the left displays the
time dependency of the labeling reaction (lane 1–6; 0.25, 0.5, 1, 2, 4 and
8h). The panel on the right shows the impact of KOH detachment time
during PAR isolation on subsequent biotin-labeling (lane 7–12; 5, 15,
30, 45, 60 and 120min).
Figure 2. Interaction of fractionated PAR and immobilized proteins.
(A) Recombinant puriﬁed p53 was vacuum-aspirated onto a nitrocellu-
lose membrane using a slot-blot manifold (15pmol/slot). The mem-
brane was cut into slices and incubated with PAR fractions comprising
distinct polymer size classes. After several washing steps with high
stringency to disrupt unspeciﬁc protein–polymer interactions, bound
PAR was detected by monoclonal antibody 10H followed by incuba-
tion with goat a-mouse HRP and peroxidase reaction. A representative
slot-blot with triplicate determinations is shown. (B) Comparison of
PAR binding with regard to chain length between XPA and p53.
Signal intensity is indicated in arbitrary units. The bars represent
mean+SEM of triplicates. Note the superior binding capacity of XPA
for 20–49-mers, compared to p53.
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Short chains of up to 20 ADP-ribose moieties displayed
weak aﬃnity for XPA similar to the experiments
performed with p53 (Figure 2B). Interestingly, PAR
chains of 20–40units showed higher aﬃnity to XPA,
compared to p53. PAR with more than 40 ADP-ribose
units bound very tightly to XPA, comparable to p53.
Taken together, these experiments indicated a pivotal
role of PAR chain length for regulating PAR–protein
interactions.
Proteins displaydifferential binding forPAR depending
on chain length
To further analyze the non-covalent interaction of PAR
and binding proteins as a function of chain length, a PAR
EMSA was established. Increasing concentrations of
recombinant XPA were incubated with ﬁxed amounts of
avidin aﬃnity-puriﬁed short ADP-ribose chains (16-mer)
and samples were subjected to native PAGE. Free as
well as bound PAR polymer was detected via the terminal
biotin-label using streptavidin–POD (Figure 3A). No
speciﬁc interaction of XPA with short ADP-ribose
chains was observed. At high XPA concentrations appar-
ently some binding of PAR did occur, however without
formation of a deﬁned complex. Using long PAR chains
(55-mer) XPA produced a complex in a concentration-
dependent manner (Figure 3B). A concentration of 0.6mM
XPA was suﬃcient for complete binding of the available
free polymer. Densitometric evaluation of the blots is
depicted in Figure 3C, displaying the signiﬁcant diﬀerence
in PAR binding. In contrast, p53 promoted speciﬁc
complex formation with short-PAR chains starting at
0.1mM of p53 (Figure 3D). PAR was almost completely
bound at 0.8mM p53, as was detected by the formation
of one discrete complex appearing at the top of the gel.
The same set of experiments was repeated using long
ADP-ribose molecules with an average chain length of
55 units (Figure 3E). Binding was detected already at or
above 0.1mM p53 and was nearly complete at 0.2mM
demonstrating the higher aﬃnity of p53 for long chains.
Strikingly, we observed that p53 was able to form three
distinct speciﬁc complexes with long-PAR chains at higher
concentrations. Blots were quantiﬁed and summarized
clearly indicating the diﬀerent aﬃnities of p53 with regard
to chain length (Figure 3F). Since all measurements were
made in equilibrium, the EMSA results allowed the
calculation of KD values representing the aﬃnities of the
respective proteins to the isolated PAR chains. The KD
values we determined were all in the nanomolar range,
demonstrating the high aﬃnity of this non-covalent
interaction (Table 1; Supplementary Table S1). In addi-
tion, there exists a binding speciﬁcity with regard to chain
length as XPA was not able to form a speciﬁc complex
with short ADP-ribose molecules in solution.
Figure 3. Interaction of fractionated PAR and binding proteins in solution as assessed by EMSA. Brieﬂy, biotinylated PAR of a deﬁned size was
incubated with binding proteins and subjected to native PAGE followed by semi-dry blotting. Bound and free ADP-ribose chains were detected using
streptavidin–POD. (A) Binding of short PAR chains (16-mer) to XPA. (B) Binding of long PAR chains (55-mer) to XPA. (C) Quantitative evaluation
of XPA gel shifts. Shift (%) was calculated as follows: signal intensity complexed PAR/(complexed+free PAR). Data are expressed as mean+SEM
of triplicates from two independent experiments. (D) Binding of short PAR chains (16-mer) to p53. (E) Binding of long PAR chains (55-mer) to p53.
(F) Evaluation of p53 gel shifts as described in (C).
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To obtain more quantitative information we performed
SPR real-time binding studies. SPR systems are optical
biosensors that allow probe-free quantitative analysis of
biomolecular interactions (39). Two diﬀerent biotinylated
PAR chains (14-mer and 63-mer) were immobilized on
streptavidin-coated sensor chips. Successful immobiliza-
tion was checked by using monoclonal PAR antibody
10H. Speciﬁcity of the sensor surface was tested using
BSA, which did not interact with the immobilized PAR
at all (data not shown). Regeneration conditions were
established successfully except for p53, which was there-
fore analyzed using kinetic titrations (40).
Antibody 10H showed very high aﬃnity and fast
association to both short and long PAR chains. Curves
were ﬁtted with a bivalent binding model (Figure 4A and
B). The binding equilibrium of the ﬁrst binding event was
calculated to be 2.8nM for the short and 0.35nM for the
long PAR chain (Table 1; Supplementary Table S1).
Using XPA at up to 500nM, no signiﬁcant binding was
observed with the short PAR oligomer whereas XPA
displayed high aﬃnity for long PAR chains (63-mer) with
a KD value of 6.5nM (Table 1; Supplementary Table S1)
and thus conﬁrming the results obtained by EMSA
(Figure 4C and D). Best ﬁts of the resulting data were
obtained using a conformational change binding model
based on the assumption that ﬁrst a weakly bound binding
state between the PAR chain and XPA is formed and a
second tighter binding state is reached after a conforma-
tional change (41). In contrast, p53 displayed strong
binding to both short and long PAR chains (Figure 4E
and F). Especially for long PAR chains binding behavior
is diﬃcult to describe as p53 forms up to three PAR–
protein complexes as shown in EMSA experiments
(Figure 3E). Using short PAR chains (14-mer) satisfactory
ﬁtting of the data was achieved with the Langmuir (1:1)-
binding model (40) providing a KD value of 3.4nM
(Table 1; Supplementary Table S1). These data are in line
with the EMSA experiments, showing that p53 produces
a single complex with short polymer.
Furthermore, we were able to estimate the stoichiome-
try of the PAR–protein complexes, using the observed
maximum binding capacity Rmax of the respective protein,
the molecular weight ratio of the diﬀerent analytes
and ligands and the immobilized amount of PAR
(Supplementary Table S1) (42). Disregarding the possibi-
lity of protein multimerization, antibody 10H displayed
the highest binding stoichiometry with up to 21 molecules
per 63-mer, implicating that one antibody molecule
requires only 3–4 ADP-ribose units for eﬃcient binding.
p53 required 4–6 ADP-ribose units for eﬃcient binding
to long PAR. XPA showed a stoichiometry of four protein
molecules per 63-mer chain and therefore requires 16
ADP-ribose units for binding. It should be mentioned that
these values are only estimates due to the low amount
of immobilized PAR (see Material and Methods section)
and neglected protein oligomerization before or after
binding to the surface, which is already known to occur
in the case of p53 (43).
DISCUSSION
We have shown that eﬃcient terminal biotinylation
of ADP-ribose chains is feasible and provides a novel,
versatile tool to study the non-covalent PAR–protein
interaction in liquid as well as in solid phase experiments.
Previous approaches have explored photoreactive biotin
analogs or biotinylated NAD
+ to label PAR chains,
leading to the unselective incorporation of several biotin
moieties (44,45). Other studies used
32P-NAD
+ to label
PAR radioactively (18,19), which is however not suited for
large-scale preparations and does not oﬀer the advantages
of an aﬃnity tag, e.g. biotin. In contrast, terminal modiﬁ-
cation of PAR with biotin allowed speciﬁc immobilization
of separated ADP-ribose chains on streptavidin-coated
surfaces and permitted the use in other applications such
as EMSA.
Recent protocols have used analytical anion exchange
HPLC and MonoQ anion exchange FPLC to size-
fractionate up to 100nmol PAR (19,36). Unlike these
methods, the established semi-preparative HPLC allowed
the fractionation of up to 10mmol of PAR, which is
equivalent to 100 runs using analytical HPLC.
By means of a slot blot assay we showed that the chain
length of PAR has a strong eﬀect on its interaction with
p53 and XPA. p53 displayed lower aﬃnity for ADP-ribose
chains of up to 39 units, but strongly bound long-PAR
chains. Binding of separated ADP-ribose chains to XPA
is also inﬂuenced by polymer size and increased with
growing chain length.
The immobilization of proteins on a membrane results
in an enhanced rigidity of the protein and is likely to alter
protein conformation, which may aﬀect polymer binding.
To overcome such possible limitations, we developed
a novel PAR-EMSA using end-biotinylated, fractionated
PAR chains. We observed that p53 could interact with
both short (16-mer) and long chains (55-mer), promoting
the formation of speciﬁc complexes. Interestingly, p53
formed three distinct complexes with long PAR chains
whereas only one complex was produced with short chains
at high p53 concentrations. This suggests that long
PAR chains induce higher molecular weight complexes
Table 1. Equilibrium constants derived from EMSA and SPR studies
on the binding of proteins to fractionated PAR
16/14-mer PAR KD [M] 55/63-mer PAR KD [M]
EMSA XPA NB 3.210
77.710
9
SPR XPA
a NB 6.510
91.310
10
EMSA p53 2.510
73.810
8 1.310
74.210
9
SPR p53
b 3.410
91.010
11 NM
SPR 10H
c 2.810
9d 1.210
12 3.510
10 d3.010
12
NB indicates no binding observed with up to 500nM analyte.
NM indicates no model found for describing such complex binding.
aOriginal data ﬁtted with conformational change model.
bOriginal data deriving from kinetic titration (40) ﬁtted 1:1.
cOriginal data ﬁtted with bivalent binding model.
dEquilibrium dissociation constant obtained from (kd1/ka1).
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Another possibility is that p53 complexes are formed
in solution due to the increasing p53 concentration, but
in the same experimental setup using short PAR chains
such higher order structures of p53 were not observed
(Figure 3D). Additionally, p53 harbors three PAR-
binding sites and each of them may form independent
complexes depending on their respective aﬃnities. This
hypothesis is conﬁrmed by SPR measurements of single
p53 injections which are best ﬁtted with a binding model
assuming three independent binding domains and three
diﬀerent resulting complexes (data not shown). Two PAR-
binding sites are located in the DNA-binding domain and
another motif resides in the tetramerization domain (20).
Oligomerization of p53 is known to be pivotal for DNA
binding and its aﬃnity to its DNA consensus sequence
(43). The high aﬃnity of short and, even more so, of long
PAR chains to p53 therefore support the ﬁnding that PAR
dramatically reduces the sequence-speciﬁc and the unspe-
ciﬁc DNA binding of p53 (21).
Additionally, the binding properties of the nucleotide
excision repair (NER) protein XPA to PAR of deﬁned
chain length were assessed using EMSA and SPR tech-
nique. Unlike p53, XPA did not form a speciﬁc complex
with short chains, but produced a complex with long
ADP-ribose molecules (55-mer) in a concentration-
dependent manner (Figure 3B). XPA showed a compar-
able aﬃnity for long-PAR chains as p53, being in the
nanomolar range. These results were conﬁrmed using
the SPR approach, which showed no interaction of XPA
Figure 4. SPR real-time binding studies with PAR 14-mer (A, C and E) and 63-mer (B, D and F). Experimental data are depicted in black and
ﬁtted curves in red. (A) Sensorgram of binding of antibody 10H (various concentrations from 0.01 to 10nM) to PAR 14-mer using bivalent binding
model for data evaluation. (B) Sensorgram for antibody 10H (various concentrations from 0.01 to 10nM) binding to PAR 63-mer and bivalent
binding model for data evaluation. (C) Sensorgram for XPA (50 and 100nM) injected over immobilized PAR 14-mer. Even at 500nM XPA no
binding was observed. (D) Sensorgram for XPA binding to PAR 63-mer, with data ﬁtted using a conformational change binding model. (E) Kinetic
titration sensorgram for p53 binding to PAR 14-mer using a 1:1 binding model for data ﬁtting. (F) Kinetic titration sensorgram for p53 binding
to PAR 63-mer. Due to complex binding behavior (up to three diﬀerent complexes) no satisfactory data ﬁt was possible.
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stoichiometry for the non-covalent PAR–XPA interac-
tion indicated that 16 ADP-ribose units are necessary
for binding. Furthermore, SPR demonstrated that XPA
binds to immobilized long PAR chains (63-mer) with
considerably high aﬃnity, i.e. in the low nanomolar range
(Figure 4D). KD values derived from SPR measurements
are 50-fold lower compared to EMSA analysis, which is
a general phenomenon already been described in the
literature (46). XPA is involved in damage veriﬁcation
during NER and anchors structure-speciﬁc endonucleases
to the damaged site (47). Additionally, it can interact
with the transcription factor TFIIH. A PAR-binding site
has been identiﬁed in the C-terminal part of XPA
overlapping with the TFIIH interaction domain (20). It
is conceivable that non-covalent interaction with long
PAR molecules reduces DNA binding of XPA and/or
may interfere with TFIIH protein interaction. Therefore,
PAR might play a role in regulating XPA activity
during NER.
In the present study, we established PAR chain length
as a crucial determinant for speciﬁc, high-aﬃnity non-
covalent interactions with proteins. Depending upon the
cellular situation, e.g. the presence of mild genotoxic
stress, PARPs might catalyze the synthesis of PAR chains
varying in chain length and branching complexity in order
to recruit speciﬁc proteins and modulate their functions.
A growing body of evidence shows that the activity of
PARP-1 is tightly regulated by phosphorylation and
protein interactions (48–51). For example, it was recently
reported that NMN adenylyl transferase 1 (NMNAT-1),
an enzyme involved in NAD
+ biosynthesis, functionally
associates with PARP-1 thereby stimulating PARP-1
activity (51). Such interaction is likely to change the
pattern of synthesized PAR with regard to chain length
and branching. Strikingly, overexpression of NMNAT-1
resulted in increased translocation of apoptosis-inducing
factor (AIF) upon oxidative stress, which ﬁts with the
previous observations that in response to severe genotoxic
stress PAR formation is a death signal and triggers
the release of AIF leading to caspase-independent cell
death (52–54). Interestingly, it was observed that it was
especially long-chain PAR with more than 60 ADP-ribose
residues that induced high rates of cell death, whereas
short polymers with 16 ADP-ribose units had only little
eﬀect on cell survival. This underscores the importance of
PAR as a signaling molecule and emphasizes the pivotal
role of PAR chain length. Our data demonstrate for the
ﬁrst time that the aﬃnity of the non-covalent PAR
interactions with speciﬁc binding proteins (XPA, p53)
can be very high (nanomolar range) and is dependent both
on the PAR chain length and on the binding protein.
Moreover, we developed an eﬃcient protocol for the
large-scale preparation of size-fractionated, biotinylated
PAR and established several novel methods, particularly
EMSA and SPR, to study the interaction of PAR and
speciﬁc binding proteins as a function of PAR chain
length. These new tools will be instrumental for the precise
characterization of this non-covalent binding and for
clariﬁcation of the signaling role of ADP-ribose polymers.
ACKNOWLEDGEMENTS
The authors would like to thank Prof. M. Scheﬀner,
Konstanz, Germany for the generous gift of the p53
baculovirus and for using BIAevaluation software 4.1.,
Prof. H. Naegeli, Zu ¨ rich, Switzerland for kindly providing
XPA cDNA, Prof. M. Miwa and Prof. T. Sugimura,
Tokyo, Japan, for 10H hybridoma cells and Dr Sascha
Beneke, Konstanz, Germany for advice on the baculovirus
system. This work was supported by the Deutsche
Forschungsgemeinschaft (Forschergruppe 434). Funding
to pay the Open Access publication charges for this article
was provided by the Deutsche Forschungsgemeinschaft.
Conﬂict of interest statement. None declared.
REFERENCES
1. Ame,J.C., Spenlehauer,C. and de Murcia,G. (2004) The PARP
superfamily. Bioessays, 26, 882–893.
2. D’Amours,D., Desnoyers,S., D’Silva,I. and Poirier,G.G. (1999)
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear
functions. Biochem. J., 342, 249–268.
3. Braun,S.A., Panzeter,P.L., Collinge,M.A. and Althaus,F.R. (1994)
Endoglycosidic cleavage of branched polymers by poly(ADP-ribose)
glycohydrolase. Eur. J. Biochem., 220, 369–375.
4. Meyer,R.G., Meyer-Ficca,M.L., Whatcott,C.J., Jacobson,E.L. and
Jacobson,M.K. (2007) Two small enzyme isoforms mediate
mammalian mitochondrial poly(ADP-ribose) glycohydrolase
(PARG) activity. Exp. Cell Res., 313, 2920–2936.
5. Mendoza-Alvarez,H. and Alvarez-Gonzalez,R. (2001) Regulation
of p53 sequence-speciﬁc DNA-binding by covalent poly(ADP-
ribosyl)ation. J. Biol. Chem., 276, 36425–36430.
6. Thorslund,T., von Kobbe,C., Harrigan,J.A., Indig,F.E.,
Christiansen,M., Stevnsner,T. and Bohr,V.A. (2005) Cooperation of
the Cockayne syndrome group B protein and poly(ADP-ribose)
polymerase 1 in the response to oxidative stress. Mol. Cell. Biol., 25,
7625–7636.
7. Adamietz,P. and Rudolph,A. (1984) ADP-ribosylation of nuclear
proteins in vivo. Identiﬁcation of histone H2B as a major acceptor
for mono- and poly(ADP-ribose) in dimethyl sulfate-treated
hepatoma AH 7974 cells. J. Biol. Chem., 259, 6841–6846.
8. Poirier,G.G., de Murcia,G., Jongstra-Bilen,J., Niedergang,C. and
Mandel,P. (1982) Poly(ADP-ribosyl)ation of polynucleosomes
causes relaxation of chromatin structure. Proc. Natl
Acad. Sci. USA, 79, 3423–3427.
9. Kameoka,M., Ota,K., Tetsuka,T., Tanaka,Y., Itaya,A.,
Okamoto,T. and Yoshihara,K. (2000) Evidence for regulation of
NF-kappaB by poly(ADP-ribose) polymerase. Biochem. J., 346,
641–649.
10. Masson,M., Niedergang,C., Schreiber,V., Muller,S.,
Menissier-de Murcia,J. and de Murcia,G. (1998) XRCC1 is
speciﬁcally associated with poly(ADP-ribose) polymerase and
negatively regulates its activity following DNA damage. Mol. Cell.
Biol., 18, 3563–3571.
11. Prasad,R., Lavrik,O.I., Kim,S.J., Kedar,P., Yang,X.P., Vande
Berg,B.J. and Wilson,S.H. (2001) DNA polymerase beta-mediated
long patch base excision repair. Poly(ADP-ribose)polymerase-1
stimulates strand displacement DNA synthesis. J. Biol. Chem., 276,
32411–32414.
12. Schreiber,V., Ame,J.C., Dolle,P., Schultz,I., Rinaldi,B., Fraulob,V.,
Menissier-de Murcia,J. and de Murcia,G. (2002) Poly(ADP-ribose)
polymerase-2 (PARP-2) is required for eﬃcient base excision DNA
repair in association with PARP-1 and XRCC1. J. Biol. Chem., 277,
23028–23036.
13. Meyer,R., Muller,M., Beneke,S., Kupper,J.H. and Burkle,A. (2000)
Negative regulation of alkylation-induced sister-chromatid exchange
by poly(ADP-ribose) polymerase-1 activity. Int. J. Cancer, 88,
351–355.
14. Simbulan-Rosenthal,C.M., Haddad,B.R., Rosenthal,D.S.,
Weaver,Z., Coleman,A., Luo,R., Young,H.M., Wang,Z.Q.,
e143 Nucleic Acids Research, 2007, Vol. 35, No. 21 PAGE8 OF 9Ried,T. et al. (1999) Chromosomal aberrations in PARP(-/-) mice:
genome stabilization in immortalized cells by reintroduction of
poly(ADP-ribose) polymerase cDNA. Proc. Natl Acad. Sci. USA,
96, 13191–13196.
15. Masutani,M., Nakagama,H. and Sugimura,T. (2005)
Poly(ADP-ribosyl)ation in relation to cancer and autoimmune
disease. Cell Mol. Life Sci., 62, 769–783.
16. Burkle,A. (2005) Poly(ADP-ribose). The most elaborate metabolite
of NAD+. FEBS J., 272, 4576–4589.
17. Minaga,T. and Kun,E. (1983) Probable helical conformation of
poly(ADP-ribose). The eﬀect of cations on spectral properties.
J. Biol. Chem., 258, 5726–5730.
18. Alvarez-Gonzalez,R. and Jacobson,M.K. (1987) Characterization of
polymers of adenosine diphosphate ribose generated in vitro and
in vivo. Biochemistry, 26, 3218–3224.
19. Kiehlbauch,C.C., Aboul-Ela,N., Jacobson,E.L., Ringer,D.P. and
Jacobson,M.K. (1993) High resolution fractionation and charac-
terization of ADP-ribose polymers. Anal. Biochem., 208, 26–34.
20. Pleschke,J.M., Kleczkowska,H.E., Strohm,M. and Althaus,F.R.
(2000) Poly(ADP-ribose) binds to speciﬁc domains in DNA damage
checkpoint proteins. J. Biol. Chem., 275, 40974–40980.
21. Malanga,M., Pleschke,J.M., Kleczkowska,H.E. and Althaus,F.R.
(1998) Poly(ADP-ribose) binds to speciﬁc domains of p53 and alters
its DNA binding functions. J. Biol. Chem., 273, 11839–11843.
22. El-Khamisy,S.F., Masutani,M., Suzuki,H. and Caldecott,K.W.
(2003) A requirement for PARP-1 for the assembly or stability
of XRCC1 nuclear foci at sites of oxidative DNA damage.
Nucleic Acids Res., 31, 5526–5533.
23. Okano,S., Lan,L., Caldecott,K.W., Mori,T. and Yasui,A. (2003)
Spatial and temporal cellular responses to single-strand breaks in
human cells. Mol. Cell. Biol., 23, 3974–3981.
24. Malanga,M. and Althaus,F.R. (2004) Poly(ADP-ribose) reactivates
stalled DNA topoisomerase I and Induces DNA strand break
resealing. J. Biol. Chem., 279, 5244–5248.
25. Haince,J.F., Kozlov,S., Dawson,V.L., Dawson,T.M., Hendzel,M.J.,
Lavin,M.F. and Poirier,G.G. (2007) Ataxia Telangiectasia
Mutated (ATM) signaling network is modulated by a novel
poly(ADP-ribose)-dependent pathway in the early response to
DNA-damaging Agents. J. Biol. Chem., 282, 16441–16453.
26. Chang,P., Jacobson,M.K. and Mitchison,T.J. (2004)
Poly(ADP-ribose) is required for spindle assembly and structure.
Nature, 432, 645–649.
27. Schreiber,V., Dantzer,F., Ame,J.C. and de Murcia,G. (2006)
Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev.
Mol. Cell Biol., 7, 517–528.
28. Panzeter,P.L., Realini,C.A. and Althaus,F.R. (1992) Noncovalent
interactions of poly(adenosine diphosphate ribose) with histones.
Biochemistry, 31, 1379–1385.
29. Panzeter,P.L., Zweifel,B., Malanga,M., Waser,S.H., Richard,M.
and Althaus,F.R. (1993) Targeting of histone tails by poly(ADP-
ribose). J. Biol. Chem., 268, 17662–17664.
30. Kawamitsu,H., Hoshino,H., Okada,H., Miwa,M., Momoi,H. and
Sugimura,T. (1984) Monoclonal antibodies to poly(adenosine
diphosphate ribose) recognize diﬀerent structures. Biochemistry, 23,
3771–3777.
31. Beneke,S., Alvarez-Gonzalez,R. and Burkle,A. (2000) Comparative
characterisation of poly(ADP-ribose) polymerase-1 from two
mammalian species with diﬀerent life span. Exp. Gerontol., 35,
989–1002.
32. Chalkley,G.E., Knowles,P.P., Whitehead,P.C. and Coﬀer,A.I.
(1994) Biochemical characterisation of puriﬁed human wild-type
p53 overexpressed in insect cells. Eur. J. Biochem., 221, 167–175.
33. Nuber,U., Schwarz,S.E. and Scheﬀner,M. (1998) The ubiquitin-
protein ligase E6-associated protein (E6-AP) serves as its own
substrate. Eur. J. Biochem., 254, 643–649.
34. Jones,C.J. and Wood,R.D. (1993) Preferential binding of the
xeroderma pigmentosum group A complementing protein to
damaged DNA. Biochemistry, 32, 12096–12104.
35. Missura,M., Buterin,T., Hindges,R., Hubscher,U., Kasparkova,J.,
Brabec,V. and Naegeli,H. (2001) Double-check probing of DNA
bending and unwinding by XPA-RPA: an architectural function in
DNA repair. The EMBO J., 20, 3554–3564.
36. Malanga,M., Bachmann,S., Panzeter,P.L., Zweifel,B. and
Althaus,F.R. (1995) Poly(ADP-ribose) quantiﬁcation at
the femtomole level in mammalian cells. Anal. Biochem., 228,
245–251.
37. Shah,G.M., Poirier,D., Duchaine,C., Brochu,G., Desnoyers,S.,
Lagueux,J., Verreault,A., Hoﬂack,J.C., Kirkland,J.B. et al. (1995)
Methods for biochemical study of poly(ADP-ribose) metabolism
in vitro and in vivo. Anal. Biochem., 227, 1–13.
38. Panzeter,P.L. and Althaus,F.R. (1990) High resolution size analysis
of ADP-ribose polymers using modiﬁed DNA sequencing gels.
Nucleic Acids Res., 18, 2194.
39. Cooper,M.A. (2003) Label-free screening of bio-molecular interac-
tions. Anal. Bioanal. Chem., 377, 834–842.
40. Karlsson,R., Katsamba,P.S., Nordin,H., Pol,E. and Myszka,D.G.
(2006) Analyzing a kinetic titration series using aﬃnity biosensors.
Anal. Biochem., 349, 136–147.
41. Karlsson,R. and Falt,A. (1997) Experimental design for kinetic
analysis of protein–protein interactions with surface plasmon
resonance biosensors. J. Immunol. Methods, 200, 121–133.
42. Linnell,J., Mott,R., Field,S., Kwiatkowski,D.P., Ragoussis,J. and
Udalova,I.A. (2004) Quantitative high-throughput analysis of
transcription factor binding speciﬁcities. Nucleic Acids Res., 32, e44.
43. Hainaut,P., Hall,A. and Milner,J. (1994) Analysis of p53 quaternary
structure in relation to sequence-speciﬁc DNA binding. Oncogene, 9,
299–303.
44. Narendja,F.M. and Sauermann,G. (1994) The use of biotinylated
poly(ADP-ribose) for studies on poly(ADP-ribose)–protein interac-
tion. Anal. Biochem., 220, 415–419.
45. Cheung,A. and Zhang,J. (2000) A scintillation proximity assay for
poly(ADP-ribose) polymerase. Anal. Biochem., 282, 24–28.
46. Bondeson,K., Frostell-Karlsson,A., Fagerstam,L. and
Magnusson,G. (1993) Lactose repressor–operator DNA interac-
tions: kinetic analysis by a surface plasmon resonance biosensor.
Anal. Biochem., 214, 245–251.
47. Cleaver,J.E. (2005) Cancer in xeroderma pigmentosum and related
disorders of DNA repair. Nat. Rev. Cancer, 5, 564–573.
48. Kauppinen,T.M., Chan,W.Y., Suh,S.W., Wiggins,A.K., Huang,E.J.
and Swanson,R.A. (2006) Direct phosphorylation and regulation of
poly(ADP-ribose) polymerase-1 by extracellular signal-regulated
kinases 1/2. Proc. Natl Acad. Sci. USA, 103, 7136–7141.
49. Cohen-Armon,M., Visochek,L., Rozensal,D., Kalal,A., Geistrikh,I.,
Klein,R., Bendetz-Nezer,S., Yao,Z. and Seger,R. (2007)
DNA-independent PARP-1 activation by phosphorylated ERK2
increases Elk1 activity: a link to histone acetylation. Mol. Cell, 25,
297–308.
50. Keil,C., Grobe,T. and Oei,S.L. (2006) MNNG-induced cell death is
controlled by interactions between PARP-1, poly(ADP-ribose)
glycohydrolase, and XRCC1. J. Biol. Chem., 281, 34394–34405.
51. Berger,F., Lau,C. and Ziegler,M. (2007) Regulation of
poly(ADP-ribose) polymerase 1 activity by the phosphorylation
state of the nuclear NAD biosynthetic enzyme NMN adenylyl
transferase 1. Proc. Natl Acad. Sci. USA, 104, 3765–3770.
52. Andrabi,S.A., Kim,N.S., Yu,S.W., Wang,H., Koh,D.W., Sasaki,M.,
Klaus,J.A., Otsuka,T., Zhang,Z. et al. (2006) Poly(ADP-ribose)
(PAR) polymer is a death signal. Proc. Natl Acad. Sci. USA, 103,
18308–18313.
53. Yu,S.W., Andrabi,S.A., Wang,H., Kim,N.S., Poirier,G.G.,
Dawson,T.M. and Dawson,V.L. (2006) Apoptosis-inducing factor
mediates poly(ADP-ribose) (PAR) polymer-induced cell death.
Proc. Natl Acad. Sci. USA, 103, 18314–18319.
54. Yu,S.W., Wang,H., Poitras,M.F., Coombs,C., Bowers,W.J.,
Federoﬀ,H.J., Poirier,G.G., Dawson,T.M. and Dawson,V.L. (2002)
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death
by apoptosis-inducing factor. Science, 297, 259–263.
PAGE 9 OF 9 Nucleic Acids Research, 2007, Vol. 35,No. 21 e143